Wegovy vs Compounded Semaglutide
Wegovy is the FDA-approved branded semaglutide pen labeled for chronic weight management. Compounded semaglutide is prepared by a licensed pharmacy for provider-reviewed metabolic optimization when supply, cost, or titration flexibility require it.
Branded Wegovy is appropriate when supply, insurance, and standardized titration are the right fit.
Compounded semaglutide is appropriate when provider-tuned titration and continuity of supply are clinically preferred.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Are outcomes equivalent?
Both deliver semaglutide; outcomes are driven by adherence, titration, and lifestyle restructuring under provider review.
Is candidacy different?
Candidacy is the same provider-reviewed assessment; the formulation choice is downstream.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment